2021 annual financial data
Neuphoria Therapeutics 2021 Financial results
Direct answer
Revenue was 927,544 USD.
Operating income was -8,957,654 USD and net income was -6,534,408 USD.
Operating cash flow was -5,664,125 USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 927,544 USD
- Operating income
- -8,957,654 USD
- Net income
- -6,534,408 USD
- Operating cash flow
- -5,664,125 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Neuphoria Therapeutics financial years